Android app Apple app link

FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs

By CNBC   |   1 month ago
FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs

The FDA is speeding up the process to develop generic versions of complex biological drugs to lower drug costs. The agency aims to increase competition for expensive medicines, benefiting Americans. The move will cut the time to bring biosimilars to market in half.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.